Important Safety Information
Elderly patients with dementia-related psychosis (having lost touch
with reality due to confusion and memory loss) treated with this type of medicine
are at an increased risk of death, compared to placebo (sugar pill). GEODON is not
approved for treating these patients.
You should not take GEODON if you have certain kinds of heart conditions
or take certain medicines. GEODON may increase the risk of changes to your heart
rhythm. It is important to talk to your doctor about this possible side effect.
And be sure to call your doctor right away if you faint, pass out, or feel a change
in your heartbeat.
Serious side effects can occur with any antipsychotic medicine, including GEODON.
Tell your doctor right away if you experience a high fever, stiff muscles, shaking,
confusion, sweating, or increased heart rate or blood pressure. These can be signs
of a rare condition called neuroleptic malignant syndrome (NMS).
Also tell your doctor if you experience abnormal or uncontrollable facial or body
movements. These could be a sign of tardive dyskinesia (TD), which may become permanent.
Medicines like GEODON may raise blood sugar levels. There have been few reports
of high blood sugar or diabetes in patients who take GEODON. It is not known if
GEODON was the cause.
If you experience a rash, lightheadedness, or seizures while taking GEODON, tell
your doctor. Ask your doctor if GEODON is right for you.
The most common side effects for patients taking GEODON for bipolar mania include
sleepiness, abnormal muscle movements (such as tremors, shuffling, and uncontrolled
movement), dizziness, and restlessness.
The most common side effects for patients taking GEODON for schizophrenia include
sleepiness, increased cough, and runny nose.
In short-term schizophrenia clinical trials, 10% of GEODON-treated patients experienced
a weight gain of ≥7% of body weight vs. 4% for placebo.
Please see patient summary information and full prescribing information.
GZU00223A © Copyright 2008
Pfizer Inc.
All rights reserved.